Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Announces “Proactive” Approach To Rx-To-OTC Switches

This article was originally published in The Tan Sheet

Executive Summary

FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3
Advertisement

Related Content

FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process
OTC Pricing Pressures Will Grow As Uninsured Self-Medicate – Consultant
FDA OTC Funding Increase For ’04 Trimmed By House Appropriations Cmte.
FDA-Initiated OTC Switches Could Be Based On Foreign Data – McClellan
FDA Cautious On Forced Rx-To-OTC Switches
FDA In Brief
CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
OTC Sale Of Rx Allergy Drugs Would Be Safer, Cut Costs - Health Plan
OTC Sale Of Rx Allergy Drugs Would Be Safer, Cut Costs - Health Plan

Topics

Advertisement
UsernamePublicRestriction

Register

PS095109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel